Anavex Life Sciences Corp (AVXL)

[frrol]

Anavex's EV is now below $200MM, which is low to comps. The price will eventually recover somewhat. The Missling credibility discount will remain, but full, peer reviewed AD results will help overcome that. It's also good that we will be under a regulatory approval review this year.

Treat this as what it is, an investment in a risky biotech. Ignore the fantasies and conspiracies. It's a public MB, which are often loaded with kooks and panicky amateurs.